Fig. 5: CDX2 inhibits the stabilisation and nuclear translocation of β-catenin in colorectal cancer (CRC). | British Journal of Cancer

Fig. 5: CDX2 inhibits the stabilisation and nuclear translocation of β-catenin in colorectal cancer (CRC).

From: CDX2 inhibits epithelial–mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression

Fig. 5

a, b Western blotting bands for nuclear β-catenin and total/phospho-β-catenin protein in CDX2-knockdown (a) and CDX2-overexpressing (b) cells. c, e IF staining of β-catenin in CDX2-knockdown (c) and -overexpressing (e) cells. Scale bar, 50 μm. d, f ICC staining of β-catenin in CDX2-knockdown (d) and -overexpressing (f) cells. Scale bar, 10 μm. All data are presented as the mean ± SD from three independent experiments.

Back to article page